The angiotensin-converting enzyme 2 (ACE2) receptor in the prevention and treatment of COVID-19 are distinctly different paradigms
Abstract There is current debate concerning the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin II type 1 receptor blockers (ARBs), for hypertension management, during COVID-19 infection. Specifically, the suggestion has been made that ACE inhibitors or ARBs could theoretically...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
XMLink
2020-07-01
|
| Collection: | Clinical Hypertension |
| Sujets: | |
| Accès en ligne: | http://link.springer.com/article/10.1186/s40885-020-00147-x |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|